Skip to Content Facebook Feature Image

Health Authority Debunks Rumors About Vaccination Consent Forms and Organ Donation Concerns

HK

Health Authority Debunks Rumors About Vaccination Consent Forms and Organ Donation Concerns
HK

HK

Health Authority Debunks Rumors About Vaccination Consent Forms and Organ Donation Concerns

2025-09-30 23:10 Last Updated At:23:18

DH responds to media enquiries regarding Vaccination Subsidy Scheme consent forms

​In response to media inquiries regarding online rumors alleging that the consent form for the Vaccination Subsidy Scheme (VSS) contains hidden details and that the physical condition of individuals receiving seasonal influenza vaccines might be included in organ donation matching or related research, the Centre for Health Protection (CHP) of the Department of Health (DH) today (September 30) vehemently denied such claims and provided the following response:

The allegations are completely unfounded. Members of the public should not be misled.

The 2025/26 Seasonal Influenza Vaccination (SIV) Programmes comprises four programmes, namely Government Vaccination Programme, Residential Care Home Vaccination Programme, Seasonal Influenza Vaccination School Outreach Programme and VSS. Eligible high-risk groups generally need to complete a consent form before receiving free or subsidised SIV through the programmes. The consent form specifies that the information provided may be transferred to private doctors, the Primary Healthcare Commission, the Hospital Authority, the Government's agents and 15 healthcare-related statutory Boards and Councils that the DH provides secretariat support to. In the past, the consent forms of the SIV Programmes also stated that the Government may, when necessary, provide personal data obtained to other organisations (including the aforementioned 15 healthcare-related statutory Boards and Council for which the DH provides secretariat support) for the purposes of personal data collection stated in the consent form. These provisions ensure that the DH can promptly and effectively investigate any rare adverse events that may occur during the SIV programmes, such as enabling the relevant bodies to investigate serious medical incidents involving vaccine recipients. The DH will never use the information for organ donation or research on donor-recipient matching. Both paper and electronic consent forms are generally destroyed within seven years. The DH does not retain the relevant personal data either. This practice fully complies with relevant laws and requirements for protecting personal data privacy.

The CHP urged the public not to hesitate about receiving SIV due to rumours. The CHP stressed that vaccination has been scientifically proven to be one of the most effective ways to prevent seasonal influenza and its complications. It also reduces the risks of in-patient admission and mortality due to seasonal influenza. All members of the public aged six months or above, except those with known contraindications, should receive SIV every year for personal protection. As the saying goes, 'get vaccinated once a year and sooner is better than later'.

For more information on the government-subsidised SIV Programmes, please call the CHP at 2125 2125 or visit the website.

Source: AI-found images

Source: AI-found images

Secretary for Health attends 20th Joint Meeting of Senior Health Officials of Mainland, Hong Kong and Macao in Macao

The Secretary for Health, Professor Lo Chung-mau, led a delegation to attend the 20th Joint Meeting of Senior Health Officials of the Mainland, Hong Kong and Macao hosted by the Macao Special Administrative Region (SAR) Government in Macao today (January 15).

The annual Joint Meeting has long been a platform for senior medical and health officials as well as experts from the Mainland, Hong Kong and Macao to exchange views and share experiences on present-day medical and public health issues, as well as to promote healthcare service development. The Joint Meeting is hosted by the Mainland, Hong Kong and Macao in rotation.

The Minister of the National Health Commission, Mr Lei Haichao, and the Secretary for Social Affairs and Culture of the Macao SAR Government, Ms O Lam, led senior health officials from the Mainland and the Macao SAR Government respectively to participate in the meeting. Members of the delegations of the three places today engaged in sharing and discussions over three major topics, namely nurturing interdisciplinary and composite talent in clinical management, disease prevention and control, and medical administration; strengthening primary healthcare services to safeguard community health, and the application of smart healthcare in the health sector.

Professor Lo said, "The Recommendations of the Communist Party of China (CPC) Central Committee for Formulating the 15th Five-Year Plan for National Economic and Social Development, adopted at the Fourth Plenary Session of the 20th CPC Central Committee, features the term 'reform' 23 times, unequivocally underscoring the nation's steadfast commitment to deepening reforms. Hong Kong has consistently been playing an active role in the course of the country's reform and opening up. Serving as a 'super connector' between the Mainland and the world, Hong Kong also functions as an indispensable 'super value-adder', facilitating the nation's effort in going global while attracting foreign investment to the Mainland market.

"The Chief Executive of the Hong Kong Special Administrative Region (HKSAR) has consistently emphasised in the Policy Addresses of the past three years the HKSAR Government's full commitment to developing Hong Kong into an international health and medical innovation hub, and to vigorously foster new quality productive forces. To achieve this significant objective, the HKSAR Government is actively advancing various initiatives, including the setting up of the Hong Kong Centre for Medical Products Regulation within this year, with a view to establishing the Centre as an internationally recognised regulatory authority for medical products as soon as possible; the official launch of the Greater Bay Area (GBA) Clinical Trial Collaboration Platform last month, enabling pharmaceutical companies to conduct trials simultaneously in Hong Kong and Shenzhen; as well as the commissioning of the Real-World Study and Application Centre to promote the standardisation of clinical data across the GBA."

The Chief Executive of the Hospital Authority (HA), Dr Libby Lee, and the Director of Cluster Services of the HA, Dr Wong Yiu-chung, moderated a discussion and gave a presentation on the application of smart healthcare in the health sector respectively. Meanwhile, the acting Deputy Director of Health, Dr Jackie Leung, and the Commissioner for Primary Healthcare, Dr Pang Fei-chau, delivered presentations on the topic of nurturing interdisciplinary and composite talent in clinical management, disease prevention and control, and medical administration; as well as on the topic of strengthening primary healthcare services to safeguard community health respectively.

Members of the HKSAR Government delegation included the Chairman of the HA, Mr Henry Fan, and the Director of Health, Dr Ronald Lam, who concluded the discussion at the meeting.

Professor Lo will return to Hong Kong in the evening. During his absence, the Under Secretary for Health, Dr Cecilia Fan, is the Acting Secretary for Health.

Secretary for Health attends 20th Joint Meeting of Senior Health Officials of Mainland, Hong Kong and Macao in Macao Source: HKSAR Government Press Releases

Secretary for Health attends 20th Joint Meeting of Senior Health Officials of Mainland, Hong Kong and Macao in Macao Source: HKSAR Government Press Releases

Secretary for Health attends 20th Joint Meeting of Senior Health Officials of Mainland, Hong Kong and Macao in Macao Source: HKSAR Government Press Releases

Secretary for Health attends 20th Joint Meeting of Senior Health Officials of Mainland, Hong Kong and Macao in Macao Source: HKSAR Government Press Releases

Recommended Articles